0001209191-22-005261.txt : 20220127 0001209191-22-005261.hdr.sgml : 20220127 20220127183251 ACCESSION NUMBER: 0001209191-22-005261 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220125 FILED AS OF DATE: 20220127 DATE AS OF CHANGE: 20220127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shendelman Shoshana CENTRAL INDEX KEY: 0001775490 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38898 FILM NUMBER: 22564724 MAIL ADDRESS: STREET 1: C/O APPLIED THERAPEUTICS, INC. STREET 2: 340 MADISON AVENUE, 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10173 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Applied Therapeutics Inc. CENTRAL INDEX KEY: 0001697532 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 545 5TH AVENUE, SUITE 1400 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-220-9319 MAIL ADDRESS: STREET 1: 545 5TH AVENUE, SUITE 1400 CITY: NEW YORK STATE: NY ZIP: 10017 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-25 0 0001697532 Applied Therapeutics Inc. APLT 0001775490 Shendelman Shoshana C/O APPLIED THERAPEUTICS, INC. 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 1 1 1 0 President and CEO Employee Stock Option (Right to Buy) 3.33 2022-01-25 4 A 0 234616 0.00 A 2032-01-25 Common Stock 234616 234616 D Consists of compensatory Options granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. The issuer determined to make this compensatory grant of Options to the Reporting Person in lieu of a cash bonus that otherwise would have been paid with respect to 2021. All of the shares subject to the compensatory Option vested immediately upon grant. /s/ Shoshana Shendelman 2022-01-27